The California Institute for Regenerative Medicine (CIRM) is a funding agency established by Californians to accelerate regenerative medicine research to deliver treatments for patients with unmet medical needs. Established in 2004 through the passage of Proposition 71, CIRM was initially funded with $3 billion from the state of California to support ongoing research, and in 2020, was funded again with another $5.5 billion through Proposition 14 to continue the Agency’s important work.
CIRM has provided billions in funding to support stem cell, genetic research, and development programs in its portfolio. Through the Agency’s research, infrastructure, and education programs, CIRM aims to transform the field of regenerative medicine, stimulate economic growth, and improve the lives of diverse communities throughout the state. For more information go to cirm.ca.gov.
Synthego is honored to provide CIRM applicants and awardees with exclusive access to advanced CRISPR solutions. Synthego offers tailored support across discovery, preclinical, and clinical stages to enable a seamless transition from innovative research to impactful real-world therapies. If you are a CIRM awardee or applicant, reach out to us to explore your exclusive benefits with Synthego.
The G-Rex® Grant Program is a $20 million initiative by ScaleReady, Wilson Wolf Manufacturing, Bio-Techne, and CellReady, that is designed to advance the state of cell and gene therapy (CGT) manufacturing. Specifically, the program offers CGT developers the expertise, tools, and technologies needed to defray the time and cost associated with achieving organizational milestones and inflection points in a G-Rex centric platform.
The G-Rex® Grant program provides academic and commercial institutions with up to $300,000 of critical support to overcome challenges in the development of cell and gene-modified cell therapies. Institutions can establish an optimized manufacturing process, ensuring faster and more cost-effective translation of cell and gene therapies into the clinic. For more information go to scaleready.com/g-rex-grant-program.
Synthego is proud to partner with the G-Rex® Grant Program, offering exclusive discounts to grant awardees to further reduce costs and maximize the accessibility of critical resources. This partnership underscores Synthego’s commitment to advancing cell and gene therapy innovation across all stages of therapeutic development. If you are a G-Rex® Grant awardee or applicant, reach out to us to explore your exclusive benefits with Synthego.
Cart
Account
Your Orders
Sign In